David Collier, based in South San Francisco, CA, US, is currently a Chief Executive Officer at X-37, bringing experience from previous roles at Exela Pharma Sciences LLC, Velocity Pharmaceutical Development, Presidio Partners and Menlo Therapeutics Inc.. David Collier holds a 1995 - 1997 Master of Business Administration @ University of Pennsylvania. With a robust skill set that includes Investor Relations, Lifesciences, Drug Development, Angel Investing, Entrepreneurship and more, David Collier contributes valuable insights to the industry. David Collier has 5 emails on RocketReach.